1. Short title This Act may be cited as the New Era of Preventing End-Stage Kidney Disease Act . 2. Centers of Excellence on Rare Kidney Disease Research in National Institute of Diabetes and Digestive and Kidney Diseases Subpart 3 of part C of title IV of the Public Health Service Act ( 42 U.S.C. 281 et seq. ) is amended by inserting after section 426 ( 42 U.S.C. 285c ) the following new section: 426A. Centers of Excellence on Rare Kidney Disease Research in National Institute of Diabetes and Digestive and Kidney Diseases (a) Cooperative agreements and grants (1) In general The Director of the Institute may enter into cooperative agreements with, and make grants to, public and private nonprofit entities to pay all or part of the cost of planning, establishing, or strengthening, and providing basic operating support for, regional centers of excellence for rare kidney diseases, including primary glomerular disease. Such centers of excellence shall be known as NIDDK Centers of Excellence on Rare Kidney Disease Research (referred to in this section as Centers of Excellence ). (2) Purposes of centers The purposes of the Centers of Excellence funded pursuant to paragraph (1) shall be— (A) to conduct research on the causes, etiology, symptoms, diagnosis, progression, and treatment of rare kidney diseases, including glomerular diseases; (B) to increase public awareness of rare kidney diseases, particularly in rural and underserved communities